1Chaudhuri A, Behan PO. The clinical spectrum, diagnosis, pathogenesis and treatment of Hashimoto's encephalopathy( recurrent acute disseminated encephalomyelitis)[J]. Curr Med- Chem, 2003, 10(19): 1945- 1953.
2Fatourechi V. Hashimoto' s encephalopathy: myth or reality? An endocrinologist's perspective[J]. Best Pract Res Clin EndocrinolMetab, 2005, 19(1) : 53-66.
3Tamagno G. Clinical and diagnostic aspects of encephalopath- yassociated with autoimmune thyroid disease ( or Hashimoto' sencephalopathy)[J]. Intern Emerg Med, 2006, 1 (1) : 15-23.
4Ochi H, Horiuchi I, Araki N, et al. Proteomic analysis of human brain identifies alpha-enolase as a novel autoantigen inHashimoto' s encephalopathy[J].FEBS Lett, 2002, 528 (1/ 3) : 197-201.
5Ferlazzo E, RaffaeleM, Mazzu I, et al. Recurrent status ep-ilepticus as the main feature ofHashimoto's encephalopathy[J]. Epilepsy Behav, 2006, 8(1): 328-330.
6Ferracci F, Bertiato G, Moretto G. Hashimoto's encephalopathy: epidemiologic data and pathogenetic considerations[J]. J Neurol Sci, 2004, 217(2): 165-168.
5Brain L, Jellinek EH, Ball K. Hashimoto's disease and eneephalop- athy[J]. Lancet, 1966, 2:512.
6Ferlazzo E, Raffaete M, Mazzu L, et al. Recurrent status epileptic- us as the main feature of Hashimoto's encephalopathy[ J]. Epilepsy & Behav, 2006, 8: 328.
7Duffey P, Yee S, Reid IN, et al. Hashimoto's encephalopathy : post- mortem findings after fatal status epilepticus [ J ]. Neurol, 2003, 61 : 1124.
8Sheng B, Lau KK, Li HL, et al. A case of Hashimoto's encephalop- athy with demyelinating peripheral neuropathy [ J ]. Eur Neurol, 2005, 53 : 84.
9Rowland LP. Merritt's test book of neurology [ M]. 10th ed. Balti- more : Awaverly Company, 2005. 1120 - 1126.
10Matsunaga A, Yoneda M. Anti-NAE autoantibodies and clinical spectrum in Hashimoto's encephalopathy[J]. Rinsho Byori, 2009, 57 : 271.
